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The myogenic response in uremic hypertension
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The myogenic response in uremic hypertension. In common with other forms of hypertension, uremic
Background. The constriction of resistance arteries in re- hypertension is associated with a raised peripheral vascu-
sponse to an increase in transmural pressure, the myogenic re- lar resistance [15]. Most of the cardiovascular resistancesponse, is thought to be an important determinant of peripheral
to blood flow occurs in arteries of less than 200 to 300mvascular resistance and therefore of arterial blood pressure.
diameter [16]. These so-called resistance vessels possessSince raised peripheral resistance is known to occur in uremic
hypertension, abnormal myogenic constriction might be re- intrinsic contractility that is pressure-dependent; a rise in
sponsible. We sought to assess the myogenic response of resis- lumen pressure causes constriction and a fall in pressure
tance arteries from the subtotal nephrectomy rat model of
causes dilation. This response was first described a cen-uremic hypertension.
tury ago [17] and has been termed the “myogenic re-Methods. Uremic Wistar-Kyoto (WKYU) rats, and sham-
operated normotensive (WKYC) and spontaneously hyperten- sponse.” Steady-state myogenic tone probably accounts
sive (SHRC) controls were studied in parallel. Skeletal muscle for a substantial proportion of the peripheral resistance
arteries were mounted on a pressure myograph and allowed [18] and, therefore, could be important in the mainte-to develop myogenic constriction. The active internal diameter
nance of arterial pressure.was measured at increasing lumen pressures from 20 to 200
We hypothesized that increased myogenic tone mightmm Hg. Vascular smooth muscle then was relaxed in a calcium
free solution containing nitroprusside, and the passive internal contribute to uremic hypertension. We studied the myo-
diameter measured at the same pressure steps. The ratio of genic response of isolated pressurized skeletal muscle
active to passive diameter at any given pressure was used to
(cremaster) resistance arteries from uremic hypertensiveassess the myogenic response.
Wistar-Kyoto rats (WKYU). Controls comprised vesselsResults. Myogenic constriction was not increased in either
WKYU or SHRC compared to WKYC at pressures up to 180 from both normotensive (WKYC) and spontaneously
mm Hg. hypertensive (SHRC) animals, in an attempt to single
Conclusions. Increased myogenic tone is not the cause of out the effects of uremia.uremic hypertension.
METHODS
Hypertension usually accompanies chronic renal dis-
Animalsease [1]. It accelerates the rate of progression of kidney
All procedures had the prior approval of the Homefailure [2] and contributes to the high incidence of stroke
Office (Project License number 70/5014), and were per-[3], heart failure [4], and overall cardiovascular mortality
formed in accordance with the Animals Scientific Pro-[5] seen in uremia.
cedures Act, 1986. Twelve- to 14-week-old male WKYThere are several mechanisms by which chronic renal
and SHR were obtained from Harlan Ltd. (Shaw’s Farm,insufficiency might cause hypertension. These include
Oxon, UK). General anesthesia was induced for bothsodium retention [6, 7], inappropriate activity of the re-
stages of nephrectomy by intramuscular injection ofnin-angiotensin-aldosterone system [8, 9], and increased
HYPNORM 1 mL/kg body weight (fentanyl citratesympathetic nervous system activity [10, 11]. Vascular
0.315 mg/mL plus fluanisone 10 mg/mL; Janssen-Cilagendothelial dysfunction [12] and structural changes of
resistance arteries [13, 14] also might increase blood pres- Ltd., Bucks, UK), followed by intraperitoneal injection
sure in uremia. of diazepam 2.5 mg/kg (CP Pharmaceuticals Ltd., Wrex-
ham, Wales, UK). Postoperative analgesia was provided
by subcutaneous injection of buprenorphine 50 g/kgKey words: myogenic response, uremia, hypertension, myograph, resis-
tance artery, remnant kidney. (Schering-Plough Ltd., Middlesex, UK). Left subtotal
nephrectomy through a midline abdominal incision re-Received for publication June 15, 2002
moved approximately 3⁄4 of the renal mass, with totaland in revised form August 7, 2002
Accepted for publication October 8, 2002 right nephrectomy through a flank incision one week
later. WKYC and SHR animals underwent sham surgery 2003 by the International Society of Nephrology
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in which the appropriate kidney was stripped of its cap- VT, USA). First, the proximal end of the vessel was
secured around the proximal cannula with a knottedsule only. Animals were maintained for approximately
nylon strand. A servo-controlled pump generated pres-three months during which WKYC and SHRC were pair
sure within the vessel by delivering PSS to the proximalfed with their WKYU partner; ethical considerations
cannula. The pump continued to pressurize or de-pres-ensured that a minimum 20 g/day of standard rat chow
surize the system until the pressure, sensed by a semicon-was offered to controls. Several days before sacrifice,
ductor transducer, equaled a predetermined level set byunder halothane anesthesia (Concord Pharmaceuticals
the user. Thus, the proximal cannula was first pressurizedLtd., Essex, UK), an abdominal aortic catheter (0.61 mm
to approximately 10 mm Hg to flush blood from the ves-outer diameter and 0.28 mm inner diameter; Sims Portex
sel lumen, before being lowered to 5 mm Hg, while theLtd., Kent, UK) was inserted retrogradely through the
distal end of the vessel was secured to the distal cannulafemoral artery, heparinized and exteriorized through the
as above. The vessel lumen was then slowly pressurizedskin at the nape of the neck [19]. Postoperative analgesia
to 100 mm Hg, and tested for leaks. In a leak free systemwas provided by subcutaneous injection of buprenor-
it is possible to switch off the pump with no dissipationphine as required. Two to three days later conscious blood
of the previously generated pressure. If the vessel leaked,pressure was measured (pressure transducer model #60-
it was discarded. A reservoir of PSS was gassed with3003; Harvard Apparatus, Boston, MA, USA). Blood was
95% O2/5% CO2, heated, and circulated at a rate of 40drawn for analysis, and the animal killed by cervical dislo-
mL/min to the vessel chamber, which was continuouslycation. The cremaster muscle was immediately excised
monitored and maintained at pH 7.40 and 33C, theat its most proximal aspect and placed in ice-cold physio-
temperature of the cremaster muscle in vivo. After beinglogical saline solution (PSS). One vessel was studied from
placed on the stage of an inverted microscope (Nikoneach rat on the day of sacrifice. The muscle was pinned
TMS-F; Nikon Corporation, Tokyo, Japan), the vesselout on a silastic base within a petri dish containing cold
was viewed through a 10 objective lens linked throughPSS. The main branch (1A branch [19]) of the artery
a camera port to a video monitor. The distal cannulawas identified and dissected from adjacent connective
could be moved by a Vernier screw mechanism to allowtissue.
precise control of the axial length of the mounted vessel.
By this means the distance between cannula could beBiochemical and hematological analysis
adjusted to remove kinks arising from pressure-inducedPlasma creatinine concentration was determined by
changes in vessel length. The internal diameter of thethe Jaffe´ rate method using a creatinine analyzer (Beck-
vessel was measured with a video dimension analyzer.man Coulter Ltd., UK). Blood hemoglobin was mea-
sured using a -hemoglobin photometer (HemoCue Ltd., Experimental protocol
Derbyshire, UK). Vessels developed myogenic tone during equilibration
at a lumen pressure of 100 mm Hg. The pressure was thenDrugs and solutions
decreased to 20 mm Hg and at approximately 10-minute
All chemicals (Sigma-Aldrich Company Ltd., Dorset, intervals the stable active internal diameter was recorded
UK) were made up on the day of the experiment in sterile and the pressure increased by 20 mm Hg, up to a maxi-
distilled AnalaR water (Merck Ltd., Poole, Dorset, UK). mum of 200 mm Hg. Lumen pressure was then decreased
PSS had the following composition (mmol/L): 119 NaCl, to 100 mm Hg, and vascular myogenic tone abolished
4.7 KCl, 25 NaHCO3, 1.17 KH2PO4, 1.17 MgSO4, 2.0 CaCl2 by superfusing the calcium-free PSS for 30 minutes. The
and 5.5 glucose. CaCl2 was added to PSS immediately pressure steps were then repeated, and the passive inter-
prior to use. Calcium free PSS contained ethyleneglycol– nal diameter measured at each increment.
bis (-aminoethylether)-N, N-tetraacetic acid (EGTA) 1
mmol/L and sodium nitroprusside 100 mol/L. Calculations
The myogenic response was represented as the active
The pressure myograph normalized diameter, which is the active internal diame-
The method for assessing the myogenic response with ter at a given pressure (Da, myogenic constriction pres-
the pressure myograph has been described [20]. This ent) divided by the passive internal diameter at the same
technique was chosen because it allows isolated vessels pressure (Dp, myogenic constriction abolished). By this
of precise anatomical location, devoid of circulating va- means, a normalized diameter of 0.7 corresponds to a
soactive factors, to be studied. Although endothelium myogenic constriction of 100  (1.0  0.7)  30%, rela-
and nerve endings remained intact within vessels, they tive to the passive diameter.
have been shown to exert little or no effect on the myo-
Statistical analysisgenic response [21, 22]. The artery was mounted between
the two glass microcannulas (tip diameter 100 m) of the Values are expressed as the mean and by standard
error in brackets. In all comparisons there were threemyograph (Living Systems Instrumentation, Burlington,
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Table 1. Experimental animal data for WKYU (N  10),
WKYC (N  13), and SHRC (N  13)
WKYU WKYC SHRC
Mean arterial pressure
mm Hg 161 (8)a 139 (4) 193 (3)c
Blood hemoglobin g/dL 8.2 (0.6)bc 14.1 (0.5) 14.9 (0.5)
Final body weight g 298 (9)bc 361 (6) 366 (6)
Plasma creatinine lmol/L 252 (26)bc 50 (6) 54 (5)
Period of uremia/sham
uremia weeks 14.1 (0.4) 14.3 (0.4) 14.7 (0.4)
Passive diameter of artery
at 100 mm Hg lm 151 (4)d 171 (3) 150 (5)d
a P  0.02 compared to WKYC
b P  0.001 compared to SHRC
c P  0.001 compared to WKYC
d P  0.01 compared to WKYC
separate groups: WKYU, WKYC, and SHRC. There-
fore, comparisons were made using analysis of variance
(ANOVA). For single-valued variables such as plasma
creatinine, one-way ANOVA was employed. When com-
parison of a series of measurements, such as the set of
values of normalized diameter across the pressure range,
was required between groups, then repeated measures
ANOVA was chosen [23]. The Bonferroni correction
was applied to all analyses, allowing direct comparison
between any combination of two groups. The significance
level was taken as P  0.05. Fig. 1. Passive and active diameters of cremaster arteries plotted
against lumen pressure. Symbols are () WKYU, N  10; () WKYC,
N  13; () SHRC, N  13.
RESULTS
Both WKYU and SHRC were significantly hyperten-
DISCUSSIONsive compared to WKYC. WKYU were anemic, with a
lower body mass and higher plasma creatinine values than Uremic hypertension is associated with increased pe-
both WKYC and SHRC (Table 1). The low body weight ripheral vascular resistance [15]. Many endogenous agents
of WKYU was probably due to uremic anorexia; the such as noradrenaline, nitric oxide, and endothelin can
pair-fed control animals received a minimum of 20 g/day influence resistance artery tone [24]. The dominant mech-
food, and so their weight was greater than WKYU. anism responsible for small artery tone in vivo, however,
Cremaster arteries from WKYU and SHRC had smaller is not clearly established. Studies of isolated pressurized
passive internal diameters when compared to WKYC resistance vessels [19, 20] support the notion that myo-
vessels (Fig. 1). For example, at 100 mm Hg—the pres- genic constriction is critically important to basal vascular
sure selected for morphological comparison between resistance [18]. Therefore, the purpose of our current
strains in a previous study [21]—both WKYU and SHRC study was to establish whether an increased myogenic
vessels had an average diameter of approximately 20 m response could account for uremic hypertension. The
less than WKYC (Table 1). results demonstrate that myogenic tone is not increased
Ten of 18 (56%) vessels from WKYU, 13 of 19 (68%) in skeletal muscle resistance arteries (branch 1A) of ure-
from WKYC, and 13 of 14 (93%) from SHRC devel- mic hypertensive or spontaneously hypertensive rats.
oped satisfactory myogenic tone, defined here as 	10% To our knowledge this is the first description of the
constriction at 100 mm Hg. Myogenic constriction was myogenic response of a resistance artery in uremia, and
not different between groups when the sets of values of we conclude that uremic hypertension is not the result
of increased myogenic tone. However, femoral arteriesactive normalized diameter across the pressure range
were compared by repeated measures ANOVA (Fig. 2). from mildly uremic normotensive animals have shown
a small increase in spontaneous constriction comparedInspection of the active diameter-pressure relationship at
individual points demonstrated that, beyond 160 mm Hg, to controls [25], which was abolished by angiotensin con-
verting enzyme inhibitor therapy [26]. Although the fem-WKYC vessels underwent forced dilation whereas WKYU
and SHRC were able to maintain substantial constriction oral conduit artery ( 500 m passive diameter) is not
strictly comparable to the cremaster resistance artery(Fig. 1).
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scarred [32] kidneys, and consistent with this is the obser-
vation that bilateral nephrectomy in dialysis patients
causes a lowering of blood pressure and of peripheral
resistance [6, 15]. However, in both experimental renal
failure [27] and in a proportion of dialysis patients [8],
plasma renin activity is not completely autonomous, and
can be suppressed by extracellular volume expansion
such that inappropriate plasma renin activity and volume
expansion do not necessarily co-exist. Third, the sympa-
thetic nervous system is activated in uremia [10, 11],
which might increase vascular tone through noradrena-
line-induced constriction. Fourth, endothelial dysfunc-
tion is well documented in uremia [12, 33]; through lack
of endothelium-derived vasodilators, for example nitric
oxide, unopposed local and circulating vasoconstrictors
such as endothelin might maintain elevated systemic re-
sistance. Finally, structural alterations of resistance arter-
ies occur in uremia [13, 14] similar to those seen in several
forms of hypertension [34]. They comprise thickening of
the vascular wall and/or narrowing of the lumen, as was
apparent in both our WKYU and SHRC vessels, and might
impart an increased resistance on small vessels [24]. There-
fore, there are several alternative mechanisms to an ab-
normal myogenic response that are capable of raising pe-
ripheral resistance in uremic hypertension. Some of them,
Fig. 2. Normalized active diameter plotted against lumen pressure. such as increased circulating angiotensin, conceivably
Symbols are () WKYU, N 10; () WKYC, N 13; and () SHRC, might enhance the myogenic response to transluminalN  13). P value not significant between groups by repeated measures
pressure elevation in vivo, an effect that would not haveANOVA.
been observed in isolated vessels.
Our results are consistent with a previous study of
( 160m passive diameter), the matter deserves consid- spontaneously hypertensive rat arteries [20] in which myo-
eration. The renin-angiotensin system is activated early genic tone was increased, compared to control Wistar-
in the course of chronic renal failure following partial Kyoto vessels, only at high lumen pressures. In our study,
nephrectomy but, with progression of uremia, sodium beyond 160 mm Hg, vessels from SHRC and WKYU
retention occurs sufficient to suppress the aberrant renin were able to maintain constriction whereas forced dila-
system [27]. Since vascular renin is mainly derived from tion of WKYC vessels occurred. This was probably a
uptake of circulating renin of kidney origin [28, 29], and consequence of differing vessel diameters; by Laplace’s
because tissue levels tend to parallel plasma renin activ- Law, wall tension is equal to the product of lumen pres-
ity [30], myogenic responses might be expected to differ sure and radius, such that the smaller diameter SHRC
in the observed manner as uremia progresses. and WKYU arteries must have experienced less wall
If myogenic tone is normal in uremic hypertension, tension than WKYC at a given lumen pressure. How-
then it follows that increased peripheral resistance occurs ever, because the pressure experienced by small (100 to
by some other means, and several possibilities exist. First, 200 m) arteries in vivo is between 64% [35] and 80%
extracellular volume expansion due to inadequate sodium [16] of the aortic pressure, it is unlikely that the in vitro
excretion commonly occurs in renal failure [6, 7, 27], data obtained beyond 160 mm Hg are physiologically
raising cardiac output. Resistance vessels respond appro- relevant even to SHRC. Our data differ in one respect
priately with myogenic constriction to autoregulate blood from other studies that demonstrated increased slope of
flow [31], and a new equilibrium is established at which the normalized active pressure-diameter relationship of
cardiac output is near normal but arterial pressure and cremaster arteries of the spontaneously hypertensive rat
peripheral resistance are increased [7]. Second, activity [19], which we did not observe (Fig. 2) despite using the
of the renin-angiotensin-aldosterone system inappropri- same anatomical vessel. The animals we studied were
ate to the prevailing blood pressure occurs in uremia approximately 26-weeks-old at sacrifice, compared to
[8, 9], and this increases peripheral resistance through 15- to 20-weeks-old [19]. Since the myogenic response
angiotensin II-mediated vasoconstriction. This may rep- is enhanced in the spontaneously hypertensive rat during
the onset of hypertension [20], we may have observedresent an abnormal renin response from diseased or
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thelial function in isolated human uremic resistance arteries. Kid-vessels at a different stage of development. Consistent
ney Int 60:1077–1082, 2001
with this is the observation in skeletal muscle arterioles 13. Aalkjaer C, Pedersen EB, Danielsen H, et al: Morphological and
functional characteristics of isolated resistance vessels in advancedof similar myogenic properties across the physiological
uraemia. Clin Sci Lond 71:657–663, 1986pressure range in approximately 25-week-old spontane-
14. Amann K, Ritz E: Microvascular disease–the Cinderella of urae-
ously hypertensive rats compared to normotensive con- mic heart disease. Nephrol Dial Transplant 15:1493–1503, 2000
15. Kim KE, Onesti G, Swartz CD: Hemodynamics of hypertensiontrols [23].
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16. Davis MJ, Ferrer PN, Gore RW: Vascular anatomy and hydro-
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17. Bayliss WM: On the local reactions of the arterial wall to changesserved over the physiological pressure range. We conclude
in internal pressure. J Physiol 28:220–231, 1902
that increased myogenic constriction is not responsible 18. Folkow B: Transmural pressure and vascular tone - Some aspects
of an old controversy. Arch Int Pharmacodyn 324:455–469, 1962for the hypertension of chronic renal failure.
19. Falcone JC, Granger HJ, Meininger GA: Enhanced myogenic
activation in skeletal muscle arterioles from spontaneously hyper-
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